Schneeweiss, A. (2016). First-line bevacizumab-containing therapy for HER2-negative metastatic breast cancer: Final results from a prospective German study. Anticancer research, 36(3), .
Chicago-Zitierstil (17. Ausg.)Schneeweiss, Andreas. "First-line Bevacizumab-containing Therapy for HER2-negative Metastatic Breast Cancer: Final Results from a Prospective German Study." Anticancer Research 36, no. 3 (2016).
MLA-Zitierstil (9. Ausg.)Schneeweiss, Andreas. "First-line Bevacizumab-containing Therapy for HER2-negative Metastatic Breast Cancer: Final Results from a Prospective German Study." Anticancer Research, vol. 36, no. 3, 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.